207 related articles for article (PubMed ID: 20570743)
61. Cardiovascular and respiratory safety pharmacology in Göttingen minipigs: Pharmacological characterization.
Authier S; Gervais J; Fournier S; Gauvin D; Maghezzi S; Troncy E
J Pharmacol Toxicol Methods; 2011; 64(1):53-9. PubMed ID: 21570473
[TBL] [Abstract][Full Text] [Related]
62. Respiratory inductive plethysmography as a method for measuring ventilatory parameters in conscious, non-restrained dogs.
Murphy DJ; Renninger JP; Schramek D
J Pharmacol Toxicol Methods; 2010; 62(1):47-53. PubMed ID: 20435149
[TBL] [Abstract][Full Text] [Related]
63. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
[TBL] [Abstract][Full Text] [Related]
64. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of a method to correct the contractility index LVdP/dt(max) for changes in heart rate.
Markert M; Trautmann T; Groß M; Ege A; Mayer K; Guth B
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):98-105. PubMed ID: 22554385
[TBL] [Abstract][Full Text] [Related]
66. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
[TBL] [Abstract][Full Text] [Related]
67. Statistical characteristics of moxifloxacin-induced QTc effect.
Yan LK; Zhang J; Ng MJ; Dang Q
J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
[TBL] [Abstract][Full Text] [Related]
68. Comparison of freely-moving telemetry Chinese Miniature Experiment Pigs (CMEPs) to beagle dogs in cardiovascular safety pharmacology studies.
Yuan H; Zhao J; Guo J; Wu R; He L; Cui Y; Feng M; Zhang T; Hou M; Guo Q; Zhang L; Jia L; Huang C; Ye L; Peng S
J Pharmacol Toxicol Methods; 2014; 70(1):19-28. PubMed ID: 24721420
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
Sällström J; Al-Saffar A; Pehrson R
J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
[TBL] [Abstract][Full Text] [Related]
70. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
[TBL] [Abstract][Full Text] [Related]
71. The value added by measuring myocardial contractility 'in vivo' in safety pharmacological profiling of drug candidates.
Markert M; Klumpp A; Trautmann T; Mayer K; Stubhan M; Guth B
J Pharmacol Toxicol Methods; 2007; 56(2):203-11. PubMed ID: 17583538
[TBL] [Abstract][Full Text] [Related]
72. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
[TBL] [Abstract][Full Text] [Related]
73. Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing.
Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
J Pharmacol Toxicol Methods; 2015; 72():1-10. PubMed ID: 25556117
[TBL] [Abstract][Full Text] [Related]
74. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
75. In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome.
Chiba K; Sugiyama A; Hagiwara T; Takahashi S; Takasuna K; Hashimoto K
Eur J Pharmacol; 2004 Feb; 486(2):189-200. PubMed ID: 14975708
[TBL] [Abstract][Full Text] [Related]
76. A translational assessment of preclinical versus clinical tools for the measurement of cardiac contractility: comparison of LV dP/dt(max) with echocardiography in telemetry implanted beagle dogs.
Cools F; Dhuyvetter D; Vanlommel A; Janssens S; Borghys H; Geys H; Gallacher DJ
J Pharmacol Toxicol Methods; 2014; 69(1):17-23. PubMed ID: 24140387
[TBL] [Abstract][Full Text] [Related]
77. Sensitivity of two noninvasive blood pressure measurement techniques compared to telemetry in cynomolgus monkeys and beagle dogs.
Mitchell AZ; McMahon C; Beck TW; Sarazan RD
J Pharmacol Toxicol Methods; 2010; 62(1):54-63. PubMed ID: 20435151
[TBL] [Abstract][Full Text] [Related]
78. The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies.
Baublits J; Vargas HM; Engwall MJ
J Pharmacol Toxicol Methods; 2021; 109():107067. PubMed ID: 33857614
[TBL] [Abstract][Full Text] [Related]
79. Effects of methylphenidate hydrochloride on the cardiovascular system in vivo and in vitro: a safety pharmacology study.
Wakamatsu A; Nomura S; Tate Y; Shimizu S; Harada Y
J Pharmacol Toxicol Methods; 2009; 59(3):128-34. PubMed ID: 19281853
[TBL] [Abstract][Full Text] [Related]
80. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects.
Hess P; Rey M; Wanner D; Steiner B; Clozel M
Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
